Evidence map›Paper›PMID 28358008›Full record

ArticleScientific reports2017

Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.

Dong-Woo Lim, Shambhunath Bose, Jing-Hua Wang, Han Seok Choi, Young-Mi Kim, Young-Won Chin, Song-Hee Jeon, Jai-Eun Kim, Hojun Kim

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Lactate-FortifiedNutrients · 2020
    Article
  7. Article
  8. Article
  9. A Controlled FermentedFrontiers in pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dong-Woo LimDepartment of Pathology, College of Oriental Medicine, Dongguk University, Goyang, Republic of Korea.
Shambhunath BoseApplied Surface Technology Inc., 11th Floor, Bldg. A, Advance Institutes of Convergence Technology, Suwon, 16229, Republic of Korea.
Jing-Hua WangDepartments of Rehabilitation Medicine, College of Oriental Medicine, Dongguk University, Goyang, Republic of Korea.
Han Seok ChoiDivision of Endocrinology and Metabolism, Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.
Young-Mi KimCollege of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University-Seoul, Goyang, Republic of Korea.
Young-Won ChinCollege of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University-Seoul, Goyang, Republic of Korea.
Song-Hee JeonResearch Institute of Biotechnology, Dongguk University, Goyang, Republic of Korea.
Jai-Eun KimDepartment of Pathology, College of Oriental Medicine, Dongguk University, Goyang, Republic of Korea.
Hojun KimDepartments of Rehabilitation Medicine, College of Oriental Medicine, Dongguk University, Goyang, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Samjunghwan (SJH) is an herbal formula used in traditional Korean medicine. This prescription has long been used in treatment of aging and lifestyle diseases. The current study showed the effect and mechanisms of anti-hepatic steatosis action of modified SJH (mSJH) in vitro and in vivo. Treatment with mSJH resulted in significantly decreased intracellular lipid accumulation in steatosis-induced cells. Furthermore, mSJH triggered the phosphorylation of AMP-activated protein kinase and acetyl-CoA carboxylase as well as increased the expression of leptin at both protein and gene levels. In addition, C57BL6 mice fed high-fat diet (HFD) showed significant improvements in body, liver weights and fat weights; and serum, hepatic and fecal lipid parameters in response to the treatment with mSJH. Furthermore, mSJH showed favorable effects on the hepatic expression of several genes related to lipid metabolism. Betaine, one of constituents of mSJH exerted fundamental beneficial impact on FFAs-induced cells. However, the beneficial effects of mSJH were diminished upon blocking of leptin signaling by dexamethasone, suggesting the leptin signaling as a key component in mSJH-mediated modulation of lipid homeostasis. Our results suggest that mSJH exerts an anti-hepatic steatosis effect via activation of leptin and associated signaling cascades related to lipid metabolism.

Indexed as

Acetyl-CoA CarboxylaseAMP-Activated Protein KinasesAnimalsBlood GlucoseDexamethasoneDiet, High-FatFatty Acids, NonesterifiedFatty LiverHep G2 CellsHumansLeptinLipid MetabolismLiverMaleMedicine, Korean TraditionalMiceAcetyl-CoA CarboxylaseAMP-Activated Protein KinasesBlood GlucoseDexamethasoneFatty Acids, NonesterifiedLeptinPlant Extracts

Identifiers

PMID28358008
PMCPMC5371820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.